Industry Voices4 ways medical technology can help prevent the next pandemic, and even help fight this one – FierceHealthcare

Posted on by

The COVID-19 coronavirus infectious agent now exponentially spreading worldwide seems like a plague from a distant past.

In reality, pandemics have occurred regularly over the last 20 years (the SARS pandemic in 2002-03, the H5N1 bird flu epidemic in 2006-07, the H1N1 swine flu epidemic in 2009, the MERS virus in 2012-15), and, according to leading health experts, we can expect more in the near future.

The irony is that todays technology might be facilitating the spreading of localized epidemics into worldwide pandemics. Ubiquitous, same-day transportation that carried carriers of the disease from one continent to another in a matter of hours made the rapid spread of COVID-19 inevitable. The first line of defensecontainmentreally never had a chance.

But what about the upside of modern-day technology in fighting COVID-19, notably modern-day health-related hardware and software? Where has medical technology been in fighting this plague?

As it turns out, the tools for fighting pandemics are right under our noses. The medical technology to help prevent the spread of future infectious agents, and even to fight the one in our midst, exists now. Each of the four technologies discussed below has all the essential capabilities to meet the enemy head-on and, if not vanquish it, seriously curtail its harm.

Big data

Big data analytics are already being used by the Centers for Disease Control and Prevention, the World Health Organization and other agencies to track cases of COVID-19.

They use computer models with data mainly provided by Google to project its spread. Why Google? Because it gets relevant data about potential outbreaks before anyone else.

RELATED:Apple, Google team up on COVID-19 contact tracing via smartphone apps

Think about it. When a cluster of people begins searching for information about flu symptoms, thats a real-time indicator that a particular zip code could be on the verge of an outbreak. This is the power of crowd-sourced data.

At the moment, however, these data have strictly been the purview of governments and institutions. What if we democratize the data and allow everyone to benefit from predictive analytics?

The silver lining in Googles near worldwide monopoly of the internet search industry means that anyone with a laptop and wireless connection to the internet could create a Google search specific to their neighborhood, or even to their block.

Because of a lack of federal direction in the current pandemic, ordinary Americans are having to make their own decisions regarding best prevention practices, such as areas to avoid. What if we give them actual data to make informed decisions?

Teletherapeutics

With the advent of the pandemic, hospitals have shut doors to visitors. That makes perfect sense, given their need to protect not only those inside from outside pathogens but also to protect those who might enter. (After all, hospitals are essentially buildings filled with sick people in which air is circulated through the same system.)

But what if someone from the outside, say, a specialist, is required for an unusual patient case?

This is where teletherapeutics (aka telepresence, teleproctoring and telehealth) allows a person to be present without actually being there.

RELATED:Democrats voice privacy concerns about reported Kushner-led effort to collect health data

The specialist can engage remotely with the patient and other doctors in the patients own room by way of a monitor. The specialistwho might be literally thousands of miles awaycan interpret bedside data. Specialized hardware and software ensure the patients EMR(electronic medical record) isprotected at all times as well as provide the bandwidth necessary to move massive image files and big data sets required in medical diagnostics.

Smartphones

The term smartphone is the biggest misnomer since life insurance.

Your handheld device is a powerful miniature version of a mainframe computer that also happens to make and receive phone calls and text messages. Its also a potentially powerful diagnostic tool.

Rather than wait for a hospital or clinic to determine whether you might be symptomatic of COVID-19, what if you could use your smartphone to self-diagnose and triage? Right now there are apps that can determine your body temperature, respiration rate and lung volumeall key biometrics used to diagnose the virus. If your readings indicated a probability of infection, these data could then alert you to the nearest facility available for treatment.

RELATED:Boston startup using AI, remote monitoring to fight coronavirus

Similarly, the same biometrics could be triangulated to help healthcare professionals triage a massive outbreak in a contained environment. (Can we say cruise ship?)

With self-diagnosed data sent to a central source, caregivers could be alerted to which patients needed immediate attention or isolation.

AI robots

In the movie Contagion, John Hawkes plays a custodian who cleans the hospital rooms where patients have been infected with a pandemic. While the doctors and nurses wear protective gear, his character goes about his business unprotected and unscathed.

That is pure Hollywood fiction.The danger for those tasked with cleaning facilities during a pandemic is extremely high and frighteningly real.

But what if humans didnt have to be involved at all in this process? Robots are now being deployed to hospitals and clinics on the front lines of COVID-19 that use ultraviolet light to disinfect.

The advantage of UV light rather a liquid compound like bleach is that UV can zap not only hard surfaces but the air itself.

Drones are nothing more than robots that can fly. Imagine a fleet of 80 drones, working in perfect unison, to disinfect with UV light, an entire venue like a stadium. This technology is already being experimented with in Korea.

Joe S. Mullings is CEO of The Mullings Group, the worlds leading search firm in the medical technology industry. He is also the host of True | Fiction, a TV series spotlighting med-tech innovators around the world, currently available online.

Continued here:

Industry Voices4 ways medical technology can help prevent the next pandemic, and even help fight this one - FierceHealthcare

Where Is Li-ion Technology Heading? – IDTechEx.com

Posted on by

The Li-ion market is growing but which Li-ion chemistries and technologies are going to be used?

At their most basic, Li-ion cells consist of an anode, cathode and electrolyte - the anode and cathode being largely responsible for how a cell performs. While various cathode materials are used commercially, only graphite is widely used at the anode. However, this may well be set to change. Silicon has garnered industry-wide attention due its ability to store 10x the amount of lithium compared to graphite. However, the material can expand up to 300% when charging, a major issue as it leads to low cycle life. As such, start-ups developing silicon anodes have received hundreds of millions of dollars in funding to find and scale solutions to this problem. And solutions do now exist, providing various opportunities for materials manufacturers. IDTechEx believe silicon dominant anodes will soon be utilised in mass market consumer devices before being rolled-out in the automotive sector later in the decade.

The rest is here:

Where Is Li-ion Technology Heading? - IDTechEx.com

Could a New Ultraviolet Technology Fight the Spread of Coronavirus? – Columbia University

Posted on by

If widely used in occupied public places, far-UVC technology has the potential to provide a powerful check on future epidemics and pandemics, Brenner said. He added that even when researchers develop a vaccine against the virus that causes COVID, it will not protect against the next novel virus.

Our system is a low-cost, safe solution to eradicating airborne viruses minutes after they've been breathed, coughed or sneezed into the air, Brenner said. Not only does it have the potential to prevent the global spread of the virus that causes COVID-19, but also future novel viruses, as well as more familiar viruses like influenza and measles.

Brenner envisions the use of safe overhead far-UVC lamps in a wide range of indoor public spaces. The technology, which can be easily retrofitted into existing light fixtures, he said, could be deployed in hospitals and doctors offices as well as schools, shelters, airports, airplanes and other transportation hubs.

Scientists have known for decades that broad-spectrum, germicidal UV light has the capacity to kill microbes. Hospitals and laboratories often use UV light to sterilize tools and other equipment. But conventional ultraviolet light is highly penetrating and can cause skin cancer and eye problems.

In contrast, far-UVC, which has a very short wavelength, cannot reach or damage living human cells. But the narrow band wavelength can still penetrate and kill very small viruses and bacteria floating in the air or on surfaces.

Far-UVC lamps are now in production by several companies, although ramping up tolarge-scale production, as well as approval by the Food and Drug Administration and Environmental Protection Agency, will take several months. At between $500 and $1000 per lamp, the lamps are relatively inexpensive, and once they are mass produced the prices would likely fall, Brenner said.

Far-UVC takes a fundamentally different tactic in the war against COVID-19, Brenner said.Most approaches focus on fighting the virus once it has gotten into the body. Far-UVC is one of the very few approaches that has the potential to prevent the spread of viruses before they enter the body.

View post:

Could a New Ultraviolet Technology Fight the Spread of Coronavirus? - Columbia University

The Future of the American Left, Part Two: The Tactics of Our Opponents – Quad

Posted on by

Photo by Gage Skidmore (CC BY-SA 2.0)

In my first essay of this series, published last week in the Quad, I discussed what I believed were the weaknesses of Bernie Sanders candidacy for President, and how left-wing activists in America can avoid repeating that campaigns mistakes and move on in pursuit of victory. I also outlined that this second installment would be about organizing the left, and while that essay is still forthcoming, I thought it would be more logical to first discuss both what we are organizing against.

So what is the left organizing against? The true antithesis of our beliefs is the radical, fascist right-wing of American politics. The American Republican Party has trended farther and farther to the right and become more and more anti-intellectual over the course of the last few decades; until now they are led by Donald Trump, who is somehow both an imbecile and an effective fascist leader. As has been repeated ad nauseam in journalism and elsewhere, facts are no longer universally agreed upon. An insistence on being in the right is all that is required to sway support for ones ideas.

This didnt simply happen, however, and it certainly wasnt something Donald Trump or the Republican Party invented. Two other entities pioneered this vitiation of political discourse: Fox News and the alt-right movement.

Anyone who considers themselves a leftist and is reading this essay almost certainly already knows this. It is painfully apparent to anyone with critical thinking skills that Fox News has twisted the truth for as long as it has existed. It is also apparent to anyone who experiences empathy and compassion for others that the alt-right, as a whole, feels no such thing. Recognizing all this is one thing combating and defeating them is entirely another.

Both Fox and the alt-right espouse similar rhetorical tactics: forcing their opponents to perpetually explain and defend their positions; masking the facts of an issue behind a misleading and sensational statement; reducing a nuanced, complex issue down into a binary; and many others. All of these tactics are insidiously intended to portray an attitude of control and authority even when the positions they present are factually incorrect. This is the downright Machiavellian part of the far-rights tactics: their goal is never to convince the person with whom theyre debating its to convince their audience.

It is painfully apparent to anyonethat Fox News has twisted the truth for as long as it has existed.

In a debate, the natural instinct at least for people debating in good faith is to convince the other person. That natural instinct is why virtually all liberals and quite a lot of leftists are so susceptible to falling victim to the far-rights tactics and helping them achieve their rhetorical goals. Because right-wing activists and voters have in recent years more frequently resorted to rhetorical methods such as these, recognizing them for what they are is imperative if we are to successfully undermine their effectiveness.

The YouTube channel Innuendo Studios produces a series titled The Alt-Right Playbook, and while its specifically about the tactics of the alt-right, it can be applied to those of Fox News as well. Its videos are relatively short, but each thoroughly unpacks a different method the alt-right uses to change the dynamic of a political discussion. In their video The Alt-Right Playbook: Never Play Defense, they lay out specifically the tactic of forcing opponents to explain and defend their views, always seeming to be reactive to the conservatives active. This active-vs.-reactive dynamic creates the illusion for the audience that the conservative is winning the argument, while simultaneously exhausting their interlocutor.

In Never Play Defense, the videos creator and narrator Ian Danskin says, if someone tries to force you to play defense, you dont have to play, turning this particular far-right tactic against them by suggesting that refusal to engage is a valid counter to it.

In addition to that opportunity to refuse engagement, I believe that calling out and attacking the method itself is an effective oppositional response. Saying, you keep condescending and attacking, rather than engaging with the facts because you cant engage with the facts takes the power of their method and turns it against them. Now you are the one on the offensive, and the right-winger youre debating must decide whether to defend, withdraw or continue attacking. Whatever they decide, in avoiding the appearance of reacting, youve taken away their power and won.

The idea of never playing defense is a part of and supporting framework for almost all other right-wing talking points. While I dont have the space on these pages to unpack it, the tendency of Fox News to use misleading and sensational statements relies on it when their anchors or viewers are called out on spreading them is an example. The American right relies on many other spurious rhetorical practices beyond all this, and I recommend watching the entirety of Innuendo Studios The Alt-Right Playbook to learn more.

At the end of the day, it is obvious that leftists in America must learn to spot the tactics of the right and learn how to wage an effective rhetorical war against them not only to achieve victory in more theaters but to simply survive. We have been losing that rhetorical war for far too long, and its high time we fought back.

We have been losing that rhetorical war for far too long, and its high time we fought back.

Next week, the third installment of the Future of the American Left series will be published online for The Quad and will focus on what American leftists are fighting for: our goals of universal opportunity, equality and justice. The first two parts of this series were focused on how the left should operate, but in Part Three, Ill be discussing why leftist ideals exist in America in the first place. It is arguably the most important one thus far, and I hope youll look out for it.

Kyle Gombosi is a senior music: elective studies major with a minor in journalism.KG806059@wcupa.edu

Read more from the original source:

The Future of the American Left, Part Two: The Tactics of Our Opponents - Quad

Author of book about victim blaming bombarded with misogynist abuse – The Guardian

Posted on by

A British academic whose new book is about why women are blamed for crimes committed against them has been subjected to thousands of coordinated attacks from alt-right trolls over the last week, culminating in her personal computer being hacked.

Dr Jessica Taylor, a senior lecturer in forensic and criminal psychology, is due to publish her exploration of victim blaming, Why Women are Blamed for Everything, on 27 April. Looking into what causes society to blame women who have been abused, raped, trafficked, assaulted or harassed by men, the book has drawn increasing publicity, including an appearance on Womans Hour.

But since 17 April, Taylor has been targeted by what she describes as a group of organised trolls who align themselves with the alt-right, mens rights activists, incel (involuntary celibates) and Mgtow (men going their own way) movements, who have posted thousands of messages on her public Facebook page, including rape and death threats. On 21 April, Taylor contacted police when the screen on her laptop was remotely accessed. The investigation is ongoing.

They had total control of my keyboard and mouse. I tried to stop them after about 30 seconds of this, I realised how serious it was and I shut my laptop down and ran inside to turn my wifi off and shut all other devices down, Taylor told the Guardian on Friday.

For five days, she was receiving 100 comments every few minutes, everything from telling me to die, kill myself, messages saying I will rape you, messages saying I am not a real psychologist or PhD, that Im fat, ugly, disgusting, dyke, ugly lesbian, barren, infertile, will die alone, that my parents hate me etc When we started banning and blocking, they really ramped it up and it became violent and abusive.

By Friday, more than 2,000 accounts had been blocked from her Facebook page.

Taylor is the founder of VictimFocus, an international research, teaching and consultancy organisation which aims to challenge the victim blaming of women subjected to violence and abuse. Her book is based on her doctoral research and on her 10 years of practice with women and girls, including interviews with women who were blamed for being raped, and the professionals who supported them.

I knew the book needed to be written but I didnt know it needed to be written this badly. The targeted attacks from men in the last week have been appalling. I will always centre women in my work and I will keep making misogynists uncomfortable. Abuse and trolling is scary and its exhausting, but its never going to get me to a point where I say, I will just stop talking about the abuse of women and girls, said Taylor.

She said the book was written for every single woman and girl who has been told that she had to do something differently, change something about herself or make her life smaller so she isnt subjected to male violence. Ive had enough and millions of other women have had enough, too [This book] has made a lot of men angry. You have to ask why that is. What are they frightened of?

Continue reading here:

Author of book about victim blaming bombarded with misogynist abuse - The Guardian

Law Enforcement Must Be Too Busy Policing POC to Stop Swastikas and Alt-Right Gatherings – BELatina

Posted on by

Any essential work involving physical contact during the coronavirus pandemic is nothing short of commendable.

From drivers and cashiers, to law enforcement and healthcare workers, everyone who puts their lives at risk in one way or another to keep our relative normalcy going deserves much more than daily applause.

However, even during a public health crisis or perhaps precisely because of it the disparities and injustices are only doubled.

It is impossible to overlook the fact that, while Dr. Armen Henderson was arrested in Miami outside his home as he prepared for his shift to volunteer and protect people on the streets from the spread of COVID-19, there are those who can walk the streets threatening those who dare to attack their supposed freedom with guns and swastikas.

During the past week, several states in the country were the scene of protests as dystopian as the crisis itself, where hundreds of people denounced the closure imposed by state governments to prevent the spread of the virus.

Residents of Michigan, Ohio, Kentucky, and other states took to the streets at the instigation of a series of tweets from the president and thanks to the support of far-right groups such as the Proud Boys, small armed conservative militias, religious fundamentalists, anti-vaccinators and other elements of the radical right, according to The Guardian.

While some of the protests were organized by conservative coalitions and identified as Trump Republicans, their social networking collaterals, especially on Facebook, did the rest, prompting other states such as Ohio, Pennsylvania, and New York to join the demonstrations, variegatedly mixing the right to bear arms with the governors decision to impose a shelter in place.

Seeing nurses counter-demonstrate in Denver was a Dantesque image of the phenomenon that Donald Trump has fanned for years.

For those whove chosen to put their trust in science during the pandemic its hard to fathom the decision to gather to protest while a deadly viral pathogen transmitted easily by close contact and spread by symptomatic and asymptomatic people alike ravages the country, wrote Charlie Warzel in his opinion piece for the New York Times. But it shouldnt come as a surprise. This weeks public displays of defiance a march for the freedom to be infected are the logical conclusion of the modern far-rights donor-funded, shock jock-led liberty movement. It was always headed here.

Meanwhile, law enforcement continues to prioritize arrests based on race, as was the case with Dr. Henderson or underground parties in Canarsie. Immigrants continue to be confined to Immigration and Customs Enforcement detention centers with few health protocols, and undocumented citizens suffer from the governments neglect of the economic package approved by Congress.

Worse yet, in the face of demands from activist groups to release prisoners during the pandemic, the president and his party have once again seen an opportunity to put their priorities above the needs of voters.

As James Hohmann and Mariana Alfaro wrote for the Washington Post, The coronavirus spread threatens to unravel prison sentences for President Trumps former associates that career prosecutors fought hard to secure, including Rick Gates, former deputy Trump campaign chairman, Paul Manafort, Roger Stone, and former national security adviser Michael Flynn, some of whom may favor a presidential pardon and release.

If there is any doubt left about the profound flaws in the American judicial system, it is because you simply have not been paying attention.

More here:

Law Enforcement Must Be Too Busy Policing POC to Stop Swastikas and Alt-Right Gatherings - BELatina

Ben Shapiro branded as ‘white supremacist’ by student leaders who condemn his planned speech: ‘We do not have to follow the First Amendment’ -…

Posted on by

Syracuse University's Student Association in a virtual meeting passed a resolution Monday condemning conservative figure Ben Shapiro's planned speech at the school this fall, the college's paper the Daily Orange reported.

The lengthy resolution also branded Shapiro as a "white supremacist." In one rather jaw-dropping paragraph, student leaders added that "not only is Ben Shapiro a white supremacist, but he is homophobic, transphobic, xenophobic, ableist, and classist. It is inappropriate to bring someone on our campus that [sic] has actively disrespected our very own students through his language and actions."

The students' argument? "Shapiro's generalistic and harmful comments about Arabs and Palestinians promote white supremacy. When it comes to discrimination against Arabs and Palestinians, whilst Arab is considered to be an ethnicity and Palestinian is considered to be a nationality, both groups are generally racialized and discriminated [against] based on skin tone."

Oddly the same paragraph acknowledges that Shapiro "himself is Jewish and has been targeted by white nationalist terrorists" and adds that he "has not explicitly stated that the white race is better."

It's worth noting that the Boston Globe issued a correction last fall after one its columnists erroneously called Shapiro's news site, The Daily Wire, a "white supremacist-adjacent alt-right outpost."

"Because of a reporting error, the @Large column in today's Arts section, which is printed in advance, mischaracterizes the conservative media outlet The Daily Wire." Shapiro's outlet added that the correction reads, "Its founder, Ben Shapiro, has spoken out against the alt-right. The Globe regrets the error."

The Daily Wire went further in a report about the correction:

As TheBlaze has frequently reported, Shapiro is no stranger to such attacks from left-wing college students, as he's endured smears and protests amid many speaking events at schools across America over the last several years.

According to Campus Reform, one student association member during a video meeting expressed support for the resolution, said Syracuse is a private college, and added: "we do not follow the First Amendment ... Well, we do not have to follow the First Amendment. As members of the Student Association, it would be very ill-informed of us to ignore students crying out and saying they feel unsafe and to put our political beliefs and values over safety."

The resolution concluded by requesting that "the University take whatever measures are necessary to prevent [Shapiro's] event from taking place."

The student association's finance board approved the College Republicans' $39,000 request to invite Shapiro to Syracuse, the Daily Orange said, adding that he's is scheduled to come to the campus in early October.

The College Republicans' executive board released a statement rejecting the resolution, saying the organization "emphatically" disputes the notion that Shapiro is a white supremacist, the Daily Orange reported.

Read the original post:

Ben Shapiro branded as 'white supremacist' by student leaders who condemn his planned speech: 'We do not have to follow the First Amendment' -...

Bidooh co-founders admit cloning business to sell to third parties – Prolific North

Posted on by

The co-founders of Manchester-based out of home digital advertising firm Bidooh have admitted to cloning the business, followingsix months of legal action brought against them by the company.

Abdul Alim (pictured above)and Shahzad Mughal co-founded the company, whichuses facial analytics software to display tailored advertising on digital billboards, in 2016 and investors included former Manchester Unitednon-executive director Michael Edelsonand Apadmi Ventures.

However, suspicious activities were discovered by Bidooh's software engineersin August 2019. Theytracked and traced the activities of a cloned site, Flydooh, which was using IP stolen from Bidooh.

When it was revealed that Alim and Mughal had cloned the facial analytics software with a view to selling it on to third parties, Bidooh sought and obtained an interim order from Mr Justice Arnold in the High Court of Justice in London on 11th September 2019. This granted Bidoohs representatives entry to Alim and Mughals premises in order to seize and secure evidence.

It also granted Bidooh an interim injunction to halt the activities of Alim and Mughal pending full trial of the matter. From examination of the evidence, it was discovered Alim and Mughals deception went back several months and included engaging with existing Bidooh partners and clients to sell their cloned product.

A series of offensive messages relating to Bidooh employees and stakeholders were also found on their devices.

Rather than return to court, the pair admitted all claims made against them and consented to judgement being entered for the claims.

They are now required to pay Bidooh interim costs of 80,000 on account, pending a full assessment of the overall costs to which the company will be entitled to recover from them.Both have accepted that they will sell their shares back to the company for a nominal fee.

Edelson said: The final court order signifies the end of a frustrating and unfathomable chain of events. Naturally, as an investor and shareholder, I have been outraged that the people we invested a lot of belief and trust in, chose to work against us for personal gain.

Since the initiation of the first court order on 11th September 2019, a number of false counter claims have been made by Alim and Mughal against Bidooh and individuals linked to the business, which has been very distressing for all involved.

These have now been dropped and we are confident the final court order sets the record straight.

Bruce Jones, head of intellectual property at Kuits Solicitors, who acted for Bidooh, added: Abdul Alim and Shazhad Mughal appear to have mistakenly believed that they could behave as they wished.In over 30 years of legal practice I have never before encountered such flagrant infringements and abuses.

That they were undertaken by two individuals in whom so much faith and trust had been placed by investors who were willing to back them, makes their conduct all the more egregious. Im delighted for Michael and all of the team at Bidooh that we have been able to bring this case to a satisfactory conclusion.

Mughal and Alim have until 29th April to pay the interim costs to Bidooh.

Read the rest here:

Bidooh co-founders admit cloning business to sell to third parties - Prolific North

Pet Cloning Market Overview, Top Companies, Region, Application and Global Forecast by 2026 – Latest Herald

Posted on by

My friend Again

Global Pet Cloning Market Segmentation

This market was divided into types, applications and regions. The growth of each segment provides an accurate calculation and forecast of sales by type and application in terms of volume and value for the period between 2020 and 2026. This analysis can help you develop your business by targeting niche markets. Market share data are available at global and regional levels. The regions covered by the report are North America, Europe, the Asia-Pacific region, the Middle East, and Africa and Latin America. Research analysts understand the competitive forces and provide competitive analysis for each competitor separately.

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=177096&utm_source=LHN&utm_medium=888

Pet Cloning Market Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Some Notable Report Offerings:

-> We will give you an assessment of the extent to which the market acquire commercial characteristics along with examples or instances of information that helps your assessment.

-> We will also support to identify standard/customary terms and conditions such as discounts, warranties, inspection, buyer financing, and acceptance for the Pet Cloning industry.

-> We will further help you in finding any price ranges, pricing issues, and determination of price fluctuation of products in Pet Cloning industry.

-> Furthermore, we will help you to identify any crucial trends to predict Pet Cloning market growth rate up to 2026.

-> Lastly, the analyzed report will predict the general tendency for supply and demand in the Pet Cloning market.

Have Any Query? Ask Our Expert@ https://www.marketresearchintellect.com/need-customization/?rid=177096&utm_source=LHN&utm_medium=888

Table of Contents:

Study Coverage: It includes study objectives, years considered for the research study, growth rate and Pet Cloning market size of type and application segments, key manufacturers covered, product scope, and highlights of segmental analysis.

Executive Summary: In this section, the report focuses on analysis of macroscopic indicators, market issues, drivers, and trends, competitive landscape, CAGR of the global Pet Cloning market, and global production. Under the global production chapter, the authors of the report have included market pricing and trends, global capacity, global production, and global revenue forecasts.

Pet Cloning Market Size by Manufacturer: Here, the report concentrates on revenue and production shares of manufacturers for all the years of the forecast period. It also focuses on price by manufacturer and expansion plans and mergers and acquisitions of companies.

Production by Region: It shows how the revenue and production in the global market are distributed among different regions. Each regional market is extensively studied here on the basis of import and export, key players, revenue, and production.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Tags: Pet Cloning Market Size, Pet Cloning Market Growth, Pet Cloning Market Forecast, Pet Cloning Market Analysis

Our Trending Reports

Amorphous Polyethylene Terepthalate(APET) Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Amorphous Transformer Core Alloy Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

View original post here:

Pet Cloning Market Overview, Top Companies, Region, Application and Global Forecast by 2026 - Latest Herald

This self-cloning crayfish is scuttling into rivers and streams throughout Alberta – CBC.ca

Posted on by

It's not unusual to spot a trout species in a Calgary riverbut you might not expect to find a lobster-like crustacean.

In the last 10 to 20 years however, the marbled crayfish a crustacean not native to the Bow River has begun spreading to rivers and lakes throughout Alberta.

It's a problem that Nicole Kimmel, aquatic invasive species specialist for Alberta Environment and Parks, is trying to tackle.

Historically, the crustaceans are normally found in betweenWainwright andRyley in the Beaver River watershed south of Edmonton, Kimmel told The Calgary Eyeopener.

But now they've been showing up in water bodies anywhere from the Edmonton area, down to Calgary and Medicine Hat, as well as in the Milk River region.

It's not likely that the critters are crawling between rivers and lakes, though they can move on land for short periods, Kimmel said.

Instead, the provincesuspects the movements of the crayfish might be aided by humans either for bait use or they are potentially being brought back home and discarded in local waters.

"Once they're introduced to a breeding pair, they can breed pretty fast," Kimmel said the creatures can produce 200 to 400 eggs in a reproduction cycle.

Kimmel calls themarbled crayfisha kind of "freak accident" of two crayfish species that may have beenimported from Florida into Germany in the '90s and were able to mate. Through that mating, the crayfish kept an additional set of chromosomes that allowed them to reproduce asexually, meaningall the females could lay unfertilized eggs which develop into genetically identical offspring.

In essence, a self-cloning crayfish was born.

To attempt to control their spread, Alberta has banned the crayfish province-wide unless it'skept as a pet. Most pet stores have stopped carrying the specimens, but it's still possible to find them sold online by individuals.

Ducks have been munching on them, along withsome humans, but Kimmel says its important to make sure the ones used for consumption are coming from clean water sources.

Kimmel saysthe province has partnered with Mark Poesch, associate professor in Agricultural Life and Environmental Sciences at the University of Alberta, to understand what the effects are on the habitats the creatures are invading.

"We highly suspect that they're probably impacting food webs where they're being moved around," she said.

The marbled crayfish aren't the only species of their kind causing concerns there's an extensivelist of crayfish-type creatures being foundin Canadian waters,Kimmel explained.

For example, B.C. is worried about red swamp crayfish and in Manitoba there are concerns about crusty crayfish.

Meanwhile Saskatchewan, along with Alberta, has ramped up its legislation around marbled crayfish.

If you spot a crayfish, Kimmel says to report it to the provincealong with the location it was found.

"We're very much interested in knowing the location that you're finding them as well as if you can snap a picture of what they look like," Kimmel said.

"We don't want any of those other invasive ones that other jurisdictions are worried about."

The province isn't actively getting rid of the crayfish right nowuntil there's a better understanding of where the crayfishare located and what can be done for eradication.

Go here to see the original:

This self-cloning crayfish is scuttling into rivers and streams throughout Alberta - CBC.ca

Doctors and Medicine | Health Care Mythologies – ChicagoNow

Posted on by

Lucky you. Just when you were at the end of your rope and about to do something insane, I have written a post to occupy your time.

Let me begin by making something very clear. I have always tried as much as possible to make my posts apolitical.

So, I am going to make a statement, which will then lead me to the heart of today's story, but it is intended simply as an example.

Why do so many people give a flying fuck about what Trump says about the science surrounding Covid-19?

Yes, he is the president. So what?

And, so I'm not accused of just picking on him, this also goes for actor, sports figures, royalty, etc.

Stay in your lane, people!

He is a lay person and should not be considered an expert on infectious disease in any sense of the word.

OK, now here is my actual point.

When it comes to learning about science or medicine, please refer to reputable doctors or scientists.

Makes sense, right?

Yet, stop and think about the anti-vaxxers. They are not doctors or scientists, for the most part, and if they are, they are not reputable.

However, until we had huge outbreaks of measles, a completely preventable illness, I might add, we went so far as to give parents waivers, so that their children wouldn't have to be vaccinated.

Because, you know, freedom.

Now, let's talk a little more about the current scenario.

Many have pointed out, and I include myself in this group, that the flu generally has far more total impact than Covid-19, yet, we don't go into lockdown every flu season.

As time has gone on, I realize now that there are differences with Covid-19 that makes the comparison invalid.

Yes, I am admitting I was proven wrong, which is pretty amazing, if you ask me.

For the flu, there is a vaccine, which, even when it's not a "good" one, still produces immunity and lessens the severity of the disease.

Also, because of the flu vaccine, the spread is not as rampant due to the "herd immunity" effect.

Finally, of those that get severely ill and die, they fall into well defined groups, the very young and very old, or those with comorbid conditions.

In contrast, Covid-19 is extremely contagious, there is no herd immunity yet and it appears to not only kill the old, or those with co-morbid conditions, but also young, healthy people.

Not as many, granted, but enough to raise concerns.

The reason for the quarantine, which I am no more happy about than you are, is simply because the disease had completely overwhelmed our medical facilities.

I am unclear how people don't realize that.

Yes, when we are allowed to venture out again, there may well be a second wave, but the hope is it will be much smaller, so that doctors, nurses and hospitals are able to handle this surge.

That's it. That is the reason we are doing what we are doing, because in the end, it will save lives.

It sucks, I grant you, but it is necessary.

One final side note.

The outpouring of support for medical personnel is heart warming.

But, how long after this crisis is over will we once again hear about that "stupid doctor" or "sadistic nurse"?

I would really hope that people come to a better understanding now about the price those in medicine pay to do their jobs and maybe, just maybe, come away with a little more respect for them.

I don't expect it from everyone, but if it changes even a few people's opinion about the medical profession, maybe this pandemic will have at least a small silver lining.

And, for the love of God, if a non physician or scientist tries to share their "theory" about Covid-19, or anything medically related, for that matter-STAY SKEPTICAL!

Please like, share and comment and above all, stay safe!

Type your email address in the box and click the "create subscription" button. My list is completely spam free, and you can opt out at any time.

Read the original here:

Doctors and Medicine | Health Care Mythologies - ChicagoNow

We must reimagine medicine in order to protect the most vulnerable from the coronavirus – Southgate News Herald

Posted on by

I have heart disease and I am scared. For years, doctor's visits and medication have kept me alive. However, now I am afraid if I go to the doctor, I will catch coronavirus and die. If I dont go, my heart disease could kill me.

I have had similar conversations with seriously ill Americans nationwide who have a host of diseases. They are legitimately at greater risk of dying prematurely if they are exposed to the coronavirus (COVID-19).

Terminally ill patients at the end of their life face an even direr dilemma. They need access to quality medical care to control pain, manage symptoms, reduce suffering and extend their quality of life. A shortage of hospice care could drive them to seek pain and symptom management in already crowded, infectious emergency departments, which would increase their risk of a premature, painful death.

As the nation grapples to contain and treat patients with COVID-19, were rethinking how we care for people with other serious or terminal illnesses. Given that patients risk contracting the coronavirus at health care facilities designed to save lives, medicine must adopt accordingly, by replacing brick-and-mortar medicine with the safe, effective use of telehealth.

Fortunately, late last month the Centers for Medicare & Medicaid Services (CMS) issued regulations to implement telehealth provisions in the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) that significantly expand patients access to telehealth services. They will help ensure that vulnerable populations, including terminally ill patients, can seek care in the safety of their own homes while allowing quarantined doctors the ability to safely deliver quality health care.

CMS will now pay for more than 80 additional Medicare services when furnished via telehealth. They include emergency department visits, initial nursing facility and discharge visits, and home visits, which must be provided by a clinician that is allowed to provide telehealth.

Providers can evaluate Medicare beneficiaries, who have audio phones only, a vitally important option for low-tech seniors.

Licensed clinical social worker services, clinical psychologist services, physical therapy services, occupational therapist services, and speech language pathology services can receive payment for Medicare telehealth services.

Licensed practitioners, such as nurse practitioners and physician assistants, are allowed to order Medicaid home health services during the existence of the public health emergency for the COVID-19 pandemic.

Fortunately, telehealth recently has become a rapidly growing care vehicle in the United States. According to a 2018 JAMA study, annual telehealth visits have increased at an average annual compound growth rate of 52 percent from 2005 to 2017. A 2018 study by Deloitte indicates that 9 out of 10 physicians recognize the benefits of telehealth. Furthermore, two-thirds of physicians (66 percent) note that virtual care improves patient access and the majority (52 percent) recognizes it improves patient satisfaction.

Despite these promising statistics and the new CARES Act provisions, widespread adoption of telehealth will take some time. It will require buy-in by both health care providers and patients to restructure our health system and make telehealth a first-line approach, particularly during the threat of COVID-19.

If you are a patient with a terminal or serious illness or a caregiver to one, talk with your health care providers about whether telehealth could replace an in-person office visit. While it cannot substitute all office visits, it can be used in more instances than people realize. For example, clinicians are able to furnish patients with medical equipment so that they can monitor vital health indicators remotely and more effectively.

We know from experience that doctors are more likely to take the steps necessary to learn and then implement new approaches to medicine when patients request them. Given these facts, your self-advocacy for telehealth could benefit you, others, and ultimately contribute to more widespread and appropriate adoption.

Kim Callinan is president and CEO of Compassion & Choices, which works to improve care, expand options and empower everyone to chart their own end-of-life plans.

Excerpt from:

We must reimagine medicine in order to protect the most vulnerable from the coronavirus - Southgate News Herald

Schumer on Trump briefing: We have a ‘quack medicine salesman’ on TV | TheHill – The Hill

Posted on by

Senate Minority Leader Charles SchumerCharles (Chuck) Ellis SchumerDoes the country need a coronavirus testing czar? Not really State and local governments are going broke People over politics on PPP funding MORE (D-N.Y.) knocked President TrumpDonald John TrumpWH officials discuss HHS secretary replacement following criticism of pandemic response: WSJ Pentagon leaders at impasse about next steps for Capt. Brett Crozier: report Trump forgoes WH press briefing for the first time since Easter weekend MORE on Friday for questioning if injecting disinfectant could help cure the coronavirus, urging the administration to focus on ramping up testing.

"We seemed to have a quack medicine salesman on television. He's talking about things like disinfectant in the lungs," Schumer said during an interview withNPR.

"We need real focus in the White House on what needs to be done. Instead of talking about disinfectant the president should be talking about how he's going to implement testing. Which every expert says is the quickest path to get us moving again," he added.

After a presentation from a Department of Homeland Security official about the effects of disinfectants and sunlight on the virus, Trump questioned if the same techniques could be used as treatments inside the body.

I see the disinfectant, where it knocks it out in a minute, Trump said. One minute. And is there a way we can do something like that, by injection inside or almost a cleaning?

The remarks drew immediate pushback from doctors who warned against injecting or consuming household disinfectants to treat the disease. Lysol manufacturer Reckitt Benckiser on Friday issued a warning that under no circumstance should its products be administered into the human body or be used as a treatment for the coronavirus.

The White House on Friday argued that the media had taken Trump's remarks "out of context."

Congress included $25 billion for testing as part of the $484 billion coronavirus relief bill that passed both the House and Senate this week. A provision in the bill would require states to come up with plans for how to use the resources and for a national strategy from the administration on how to help states with testing.

Lawmakers, including Republicans, have warned that the United States is still lagging behind in testing. Public health experts say widely available tests are critical if social distancing restrictions are going to be lifted.

Schumer was asked by NPR if he had secured a promise from Trump on including additional state and local government aid in the next coronavirus bill, something the president and Treasury Secretary Steven MnuchinSteven Terner MnuchinSunday shows preview: Leaders weigh in as some states reopen economies; Biden deliberates a running mate US airlines get another .5 billion in federal payroll support IRS announces deadline for SSI, VA recipients to quickly get stimulus payments for children MORE have signaled they are open to.

"Commitments from President Trump come and go but we can force it to happen in the[next coronavirus] bill and I think there is enough bipartisan support ... to get that done," Schumer said.

Originally posted here:

Schumer on Trump briefing: We have a 'quack medicine salesman' on TV | TheHill - The Hill

COVID-19 Crisis Highlights The Risks Of Offshoring Pharmaceutical Manufacturing : Shots – Health News – NPR

Posted on by

Only 28% of the factories that make active ingredients for pharmaceuticals for the domestic market are located in the U.S., according to the Food and Drug Administration. Ariana Lindquist/Bloomberg via Getty Images hide caption

Only 28% of the factories that make active ingredients for pharmaceuticals for the domestic market are located in the U.S., according to the Food and Drug Administration.

The coronavirus pandemic has renewed concerns about the dependence of the United States on other countries for supplies of prescription drugs and ingredients.

The U.S. ignored the decline of domestic medical manufacturing and waited too long to seriously invest in the federal office designed to prepare for pandemics, Sen. Chris Coons, D-Del., said in an interview.

"We are now paying both in needless exposure by our front-line health workers and needless deaths for having not been better prepared for this," he says.

Nearly three-quarters of the active ingredient manufacturing facilities for medicines sold in the U.S. are located in other countries. Only 28% are domestic, according to Food and Drug Administration figures.

"Historically, the production of medicines for the U.S. population has been domestically based," Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said in congressional testimony last October. "However, in recent decades, drug manufacturing has gradually moved out of the United States."

John McShane, a managing partner at the health care product consulting firm Validant, says he remembers when drug companies shifted much of their manufacturing overseas. "I was actually a victim of the move of APIs [active pharmaceutical ingredients] out of the country," he says.

He was a plant manager for Abbott Laboratories in the late '90s and returned to manufacturing in 2005 after a few years directing broader quality and validation programs at the company. But his return was short-lived.

"Abbott was shutting five plants, including the plant I used to work at, and outsourcing all of the production," he says. "The plant I used to run has been demolished. It's basically green space and asphalt now."

Abbott and AbbVie, a 2013 spinoff focused on pharmaceuticals, declined to comment.

Major companies have "mown down" the U.S. plants that made the key components of their drugs, McShane says. By his count, the last major API facility constructed in the U.S. was built almost 30 years ago.

He says companies moved manufacturing to locations with tax incentives, like Ireland, or countries that had cheaper labor and more lax environmental laws at the time, like India and China. Mergers and acquisitions in the pharmaceutical industry have also contributed to plant closures.

The danger of offshore supply chains

Coons says the United States should have been "concerned about the offshoring of most of the critical components of the supply chain that keeps us healthy and safe."

Today, the biggest suppliers of active pharmaceutical ingredients are India and China. The COVID-19 pandemic has spurred fears of shortages because of work interruptions and changes in export policies.

"If we have another global pandemic that leads the world to close borders and leads global supply chains to shatter or to break down, we are distinctly vulnerable because we are now so dependent upon globally integrated supply chains," Coons says, adding that these concerns also apply to other medical products, such as masks and ventilators.

Research shows a continuing decline in domestic drug manufacturing in recent years. The number of domestic API facilities registered with the FDA fell about 10% from 2013 through 2019, according to research by health economists Rena Conti and Ernst Berndt of Boston University and the Massachusetts Institute of Technology, respectively.

Rebuilding U.S. pharmaceutical manufacturing would take substantial investments and patience.

"To even get to 50% of our drugs being made in the U.S., it will take one to two decades and billions of dollars," McShane says. It would likely take government incentives to lure pharmaceutical giants back home.

Pharmaceutical Research and Manufacturers of America, the main trade group for the brand-name drug industry, "supports efforts to invest in" U.S. manufacturing, spokeswoman Holly Campbell said in statement. But, she said, there are advantages to having a globalized supply chain when emergencies strike because companies can shift their sourcing to unaffected facilities.

BARDA funding for research and development

The government has tools to spur the development and manufacturing of treatments and vaccines for COVID-19.

In March, Congress appropriated $3.5 billion for the Biomedical Advanced Research and Development Authority as part of legislation to respond to COVID-19. BARDA is part of the Department of Health and Human Services, and it was created in 2006 to speed up the nation's response to bioterrorism, emerging diseases and nuclear threats.

BARDA found itself in the spotlight this week, when Rick Bright, its director since 2016, said in a statement that he was removed from his post because he insisted that the government fund "safe and scientifically vetted solutions" to COVID-19 and not on "drugs, vaccines and other technologies that lack scientific merit." He said he pushed back against funding "potentially dangerous drugs promoted by those with political connections."

BARDA awards grants to fund research and development of experimental products in the hopes of eventually adding them to the National Strategic Stockpile. It also established a network of four domestic manufacturing facilities able "to address every day and emergency needs."

To combat COVID-19, BARDA announced it will support Johnson & Johnson and Moderna as they develop experimental vaccines against the virus, and will help Johnson & Johnson scale up manufacturing capabilities so it can make up to 300 million vaccine doses annually in the U.S.

What Congress gave BARDA last month as part of the CARES Act was more money than the office had been granted in the past. And Sen. Coons says past low funding levels are a problem.

"If you go back and look at the budgets of the last few years, we were not robustly investing in this work," Coons says. "And we should have been investing in things like the national stockpile, innovation in vaccines and in therapeutics and in ensuring our supply chain before there was a crisis."

Interest in preparing for a pandemic can be cyclical, says Dana Goldman, director of the Schaeffer Center for Health Policy & Economics at the University of Southern California.

"We're faced by a crisis," he says. "We realize we're unprepared. We are willing to spend a lot of money dealing with the situation. And then as the risks seem to wane and we change administrations, it's natural when you're trying to find other money for other priorities that you would see this type of cycle."

Visit link:

COVID-19 Crisis Highlights The Risks Of Offshoring Pharmaceutical Manufacturing : Shots - Health News - NPR

New cancer treatment that tracks and zaps tumors is coming to Stanford Medicine – Stanford Medical Center Report

Posted on by

A new technology aims to make tumors their own worst enemy in the fightagainst cancer -- and Stanford Medicine will be the first in the world toincorporate the treatment into the clinic.

The first generation of a machine using this technology --the X1, fromthe company RefleXion Medical -- harnesses positron emission tomography to deliverradiation that tracks a tumor in real time. This PET feedback allows the systemto send beams of radiation to destroy cancerous cells with heightenedprecision.

Researchers hope that this "biology-guided radiotherapy" will increase accuracy, safety and efficacy of cancer radiation treatment. Stanford physicians plan to test the X1 later this year through clinical trials at Stanford Hospital. Their first step will be to obtain approval by the Food and Drug Administration.

"To my knowledge, this machine is the first of its kind. It combinestwo technologies - one traditionallyused in cancer diagnostics, and one in therapeutics -- into a singletechnology," said DanielChang, MD, professor of radiation oncology, who will lead the clinicaltrial. "That's what makes this really unique."

Radiation therapy is often one of the primary tools used to treat cancer.But the therapy, which bombards tumors with high-energy particles that killcancer cells, comes with a downside: The beam of destructive particles does notdiscriminate between cancerous and non-cancerous cells, and healthy cells areoften damaged in the line of fire.

With this new technology, the PET scanner provides continuous feedback aboutthe location of a tumor, based on the tumor's emissions, even if the tumormoves as a patient breathes. This PET feedback allows doctors to continuetraining beams of radiation on cancerous cells, even as the tumor's locationshifts. With less risk of targeting healthy cells, doctors would be better ableto zero in on tumors with higher doses of radiation, executing more accurateand precise radiation therapy, Chang said.

Samuel Mazin, PhD, co-founder and chief technology officer of RefleXion Medical, thought up the idea for the new technology while he was a Stanford postdoctoral scholar. Stanford Medicine will be the first to conduct clinical trials with the new machine. Both components of the machine -- PET scans and radiation -- have well-established safety profiles.

Chang and his colleagues hope that the technology will help open new avenuesof research, such as clinical trials for patients with multiple tumors who mayotherwise not be eligible for radiation therapy. The technology also could leadto studies to develop novel and more sensitive PET tracers -- molecules thatreveal where cancer is in the body -- to assess the inherent biology of tumorsand their response to treatment.

"We're excited about this technology for many reasons," Chang said. "Itopens up new possibilities for treatment by allowing us to deliver radiationthat tracks the tumor with extreme precision in real time -- something we're notcurrently able to do."

Photo courtesy of RefleXion 2020. All rights reserved.

Continue reading here:

New cancer treatment that tracks and zaps tumors is coming to Stanford Medicine - Stanford Medical Center Report

Nuclear Medicine Market: Find Out Essential Strategies to expand The Business and Also Check Working in 2020-2027 – Bandera County Courier

Posted on by

Market Research Inc.proclaims a new addition of comprehensive data to its extensive repository titled as, Nuclear Medicinemarket. This informative data has been scrutinized by using effective methodologies such as primary and secondary research techniques. This research report estimates the scale of the global Nuclear Medicine market over the upcoming year. The recent trends, tools, methodologies have been examined to get a better insight into the businesses.

Request a sample copy of this report @:

https://www.marketresearchinc.com/request-sample.php?id=16624

Top key players:

Cardinal Health, GE Healthcare, Curium, Bayer

This report provides a comprehensive analysis of(Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc

Additionally, it throws light on different dynamic aspects of the businesses, which help to understand the framework of the businesses. The competitive landscape has been elaborated on the basis of profit margin, which helps to understand the competitors at domestic as well as global level.

Get a reasonable discount on this premium report @:

https://www.marketresearchinc.com/ask-for-discount.php?id=16624

The globalNuclear Medicinemarket has been studied by considering numerous attributes such as type, size, applications, and end-users. It includes investigations on the basis of current trends, historical records, and future prospects. This statistical data helps in making informed business decisions for the progress of the industries. For an effective and stronger business outlook, some significant case studies have been mentioned in this report.

Key Objectives of Nuclear Medicine Market Report:

Study of the annual revenues and market developments of the major players that supply Nuclear Medicine Analysis of the demand for Nuclear Medicine by component Assessment of future trends and growth of architecture in the Nuclear Medicine market Assessment of the Nuclear Medicine market with respect to the type of application Study of the market trends in various regions and countries, by component, of the Nuclear Medicine market Study of contracts and developments related to the Nuclear Medicine market by key players across different regions Finalization of overall market sizes by triangulating the supply-side data, which includes product developments, supply chain, and annual revenues of companies supplying Nuclear Medicine across the globe.

Further information:

https://www.marketresearchinc.com/enquiry-before-buying.php?id=16624

In this study, the years considered to estimate the size ofNuclear Medicineare as follows:

History Year: 2013-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2020 to 2026.

About Us

Market Research Inc is farsighted in its view and covers massive ground in global research. Local or global, we keep a close check on both markets. Trends and concurrent assessments sometimes overlap and influence the other. When we say market intelligence, we mean a deep and well-informed insight into your products, market, marketing, competitors, and customers. Market research companies are leading the way in nurturing global thought leadership. We help your product/service become the best they can with our informed approach.

Contact Us

Market Research Inc

Kevin

51 Yerba Buena Lane, Ground Suite,

Inner Sunset San Francisco, CA 94103, USA

Call Us:+1 (628) 225-1818

Write Us@sales@marketresearchinc.com

https://www.marketresearchinc.com

Read more:

Nuclear Medicine Market: Find Out Essential Strategies to expand The Business and Also Check Working in 2020-2027 - Bandera County Courier

Reasons Why Long-term Faith on Editas Medicine, Inc. (EDIT) Could Pay Off Investors – The InvestChronicle

Posted on by

Lets start up with the current stock price of Editas Medicine, Inc. (EDIT), which is $25.01 to be very precise. The Stock rose vividly during the last session to $25.18 after opening rate of $24.05 while the lowest price it went was recorded $23.72 before closing at $24.05.

Editas Medicine, Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the companys stock is recorded $34.37 on 01/15/20, with the lowest value was $14.01 for the same time period, recorded on 03/16/20.

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stocks existing status and the future performance. Presently, Editas Medicine, Inc. shares are logging -27.23% during the 52-week period from high price, and 78.52% higher than the lowest price point for the same timeframe. The stocks price range for the 52-week period managed to maintain the performance between $14.01 and $34.37.

The companys shares, operating in the sector of healthcare managed to top a trading volume set approximately around 511835 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Editas Medicine, Inc. (EDIT) recorded performance in the market was -15.54%, having the revenues showcasing -11.78% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.33B, as it employees total of 208 workers.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 25.92, with a change in the price was noted -5.27. In a similar fashion, Editas Medicine, Inc. posted a movement of -17.40% for the period of last 100 days, recording 919,438 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the companys financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders equity. The total Debt to Equity ratio for EDIT is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Raw Stochastic average of Editas Medicine, Inc. in the period of last 50 days is set at 82.64%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 82.05%. In the last 20 days, the companys Stochastic %K was 75.42% and its Stochastic %D was recorded 72.78%.

Bearing in mind the latest performance of Editas Medicine, Inc., several moving trends are noted. Year-to-date Price performance of the companys stock appears to be encouraging, given the fact the metric is recording -15.54%. Additionally, trading for the stock in the period of the last six months notably improved by 20.04%, alongside a downfall of -7.92% for the period of the last 12 months. The shares increased approximately by 14.60% in the 7-day charts and went down by 4.21% in the period of the last 30 days. Common stock shares were lifted by -11.78% during last recorded quarter.

See original here:

Reasons Why Long-term Faith on Editas Medicine, Inc. (EDIT) Could Pay Off Investors - The InvestChronicle

University Of Maryland School Of Medicine Test Experimental Therapy To Prevent COVID-19 – CBS Baltimore

Posted on by

BALTIMORE (WJZ) Researchers at the University of Maryland School of Medicine announced Thursday they have started testing the effectiveness of hydroxychloroquine as a therapy to prevent infection and symptoms in individuals who have been exposed to COVID-19-positive individuals.

The research is part of a national study being conducted across the COVID-19 Therapeutics Accelerator.

The goal of the research is to see if hydroxychloroquine can prevent people from becoming infected with SARS-CoV-2 and getting COVID-19/coronavirus disease when taken by people who have had recent exposure to someone with the virus.

CORONAVIRUS COVERAGE:

The research is enrolling family members and frontline workers who have been exposed to individuals who have recently tested for the virus.

The study is being conducted remotely through online video calls and by answering questions via email.

Individuals who qualify for the randomized study will take either hydroxychloroquine or a placebo daily for 14 days.

Volunteers who participate in the study will be asked to take the medication, complete an online survey to assess their symptoms and collect a sample by swabbing the inside of their nose every day for 14 days. On Day 28 a final swab will be collected and a survey completed.

This study is a randomized, multi-center study, enrolling nationwide up to 2,000 men and women who meet the eligibility criteria. For more information click right here.

For the latest information on coronavirus go to theMaryland Health Departments websiteor call 211. You can find all of WJZs coverage oncoronavirus in Maryland here.

Follow this link:

University Of Maryland School Of Medicine Test Experimental Therapy To Prevent COVID-19 - CBS Baltimore

Healthy food: The unexpected medicine for COVID-19 and national security | TheHill – The Hill

Posted on by

Many in Washington are shouting follow the science. With the novel coronavirus, while there is significant confusion over effective medical treatments to prevent or cure COVID-19, one key piece of scientific evidence is beyond dispute: Those at the highest risk of extreme illness and death have underlying conditions such as obesity, diabetes, heart disease or high blood pressure. In some studies, up to 97 percent of people dying of COVID-19 have these conditions.

So, even if youre old, but not overweight, and do not have these conditions, your chances of survival are not bad. If youre young, are significantly overweight, and have these conditions, your chances of survival are much worse. In New York City, obesity was, overwhelmingly, a key risk factor for COVID-19 hospitalizations.

In the future, America will face another serious pandemic. And weve learned from COVID-19 that waiting for medical cures or preventative medicines takes too long and follows huge losses. Further, it is clear that we cant continue to shut down our economy and parts of our military, and overwhelm our health care system. We need a strategy.

From the perspectives of science and national security, the correct strategy is clear: All Americans need to eat healthier foods, lose weight, and get into good physical shape. All of this supports immunity. It is well established that obesity, diabetes, heart disease and high blood pressure are largely preventable with healthy diet and lifestyle. But healthy living is very difficult for Americans facing relentless advertising for processed and unhealthy foods, addictive (salt and sugar) ultra-processed food, entrenched and culturally-reinforced taste preferences, limited access to healthy foods for many Americans, public policy that subsidizes disease-promoting foods, sedentary behavior, and a health care and medical education system that still largely emphasizes sick care over prevention.

In the face of this mess, it can seem like the simplest course is to give up and rely on insulin, statins, blood pressure medicine and other palliative care to moderately extend lives. But the message from COVID-19 is that chronic medications dont ensure resilience against pandemic viruses. Only good physical health appears to have helped. It is, without exaggeration, a Darwinian moment for America. Americans must build personal immunity defenses through radical changes in diet and exercise, or risk getting sick and dying.

This means reducing or eliminating the seven deadly sins from our diet: processed foods, excess industrially-raised meats, refined sugar, dairy, refined grains, vegetable oils and excess sodium a revolution in personal behavior and national policy.

The personal changes are the most difficult. Americans are seeing that personal freedom can be sharply restricted during a national crisis. Perhaps now we can appreciate how much better it might be to have personal food choices redirected to avoid future serious illness or death.

The largely preventable chronic diseases that are associated with COVID-19 mortality not only make America extremely vulnerable to pandemics, they unnecessarily add hundreds of billions of dollars a year to our national medical costs and strain our health care resources. The question is how to change food habits without drastic restrictions on personal freedoms.

America could start by cutting the subsidies in our agricultural programs, specifically massive commodity support for dairy, sugar, wheat, corn and soybeans much of which is converted into livestock feed, refined oils, white flour and high fructose corn syrup. Americans are paying billions of dollars to subsidize the foods that open the door to diseases, paying trillions of dollars to support the chronic health care costs to cover diseases, and then losing trillions more in the economy when pandemics arrive.

COVID-19 is a wake-up call: America needs to refocus its agriculture towards producing cheaper and widely available organic fruits, vegetables, nuts, seeds, beans, legumes and herbs, with a massive expansion of specialty crop support, which currently represents a mere sliver of total Farm Bill spending. Similarly, USDAs unhealthy food guidance for SNAP and school meals is a disaster and dooms kids to be the victims of the COVID-19's of the future.

Within medical training, there needs to be a greater focus on nutritional and lifestyle medicine that prevents and reverses chronic disease, rather than the increasingly robotic name it, drug it and bill it style of medicine weve been evolving toward. As COVID-19 demonstrates, we can name it, but we cant drug it, so we should try to help our bodies resist it.

The lessons for the military have been sudden and harsh. Weakened troops and a carrier group shut down by the virus. It is urgent that Americas military leaders build the immunity levels of our troops through a radical change in diet. Were already struggling to recruit a healthy military because of the obesity epidemic. Now is the time for military leadership to simply mandate reduction of disease-causing food in favor of fresh, healthy food.

Were in a war and were losing because weve been fighting with poor defenses. Ironically, COVID-19 provides the secret for Americas farmers to turn their plowshares into swords.

Casey Means, M.D., is a practicing physician with a clinical focus on nutrition, nutrigenomics and disease prevention. She is an associate editor of the International Journal of Disease Prevention and Reversal, and is chief medical officer of the metabolic health company, Levels. Follow her on Instagram at @drcaseyskitchen.

Grady Means is a writer and former corporate strategy consultant. He served in the White House as a policy assistant to Vice President Nelson Rockefeller, where he chaired the Food Stamp Reform Task Force and served as White House oversight to the National Health Insurance Experiment. Follow him on Twitter @gradymeans1.

See the article here:

Healthy food: The unexpected medicine for COVID-19 and national security | TheHill - The Hill

TUESDAYS WITH JORDIE: Laughter is the best medicine – Morning Bulletin

Posted on by

LAUGHTER really is the best medicine. No, it may not be a universal bandaid that we apply in the hopes it will solve all of our problems or be the miracle medicine that cures all of our ailments but it sure can make life a whole lot better.

I feel that looking at the bright and funny side of life keeps us young at heart and lightens our load of stress/emotions/problems we find ourselves lugging through life.

Let me make myself perfectly clear to ensure my words are not twisted: I am not downplaying, mocking or dismissing the heartache and devastation the virus has caused, not by any means. I have had many sleepless nights worrying about the people around me, thinking about how theyre coping and checking in with my people. It is when I feel I am struggling within myself that my coping mechanism takes over. It gives me something positive to hold on to and keep me grounded through these hellish times.

Ive found my humour has been hyperactive of late, running rampant with rhymes, riddles and rib-ticklers, even latching on to, dare I say it, dad jokes. Sometimes in moments of monumental stress and times of torrential inner turmoil, when I have felt almost every draining emotion under the sun, laughter brings me comfort.

Laughter is like my default coping mechanism. Nothing beats being able to laugh like no one is watching; the throw-your-head-back, clutch-onto-your-sore-tummy, tears-streaming-down-your-face and uncontrollable-fits-of-giggles-flowing-from-deep-within kind of laughter, snorts and all. Thats the kind that seeps into the soul and makes everything okay, even just for a moment. It doesnt have to be pretty or airbrushed, it can simply take you wherever you let it and the people you can laugh like this with are the people who truly belong in your life.

Laughter brings me to a peaceful place and I love to share that with others, even if it is at my expense. It possesses the power to turn any pent-up pain or negative emotions into positive forces and it brings people together. I think humour has often been the underdog in our list of necessities to get through life because it has never been taken seriously. Maybe this is where we truly underestimate it because humour has always been there to bundle me up in a big hug and carry me through tough times.

It has been really nice to see communities all over the world band together, support each other and use humour to cheer each other up. There are some excellent examples of this over social media, one of my favourites being the Bin Isolation Outing group on Facebook. All age groups across all communities around the world have joined and have bin taking part in so many creative ways, each post carefully crafted with purpose: to make others smile and laugh, which all jokes aside, is so incredibly special!

I take my hat off to humour and the happiness it can bring to the world around us.

Continued here:

TUESDAYS WITH JORDIE: Laughter is the best medicine - Morning Bulletin